Literature DB >> 19177201

Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.

Johan H Gibcus1, Lu Ping Tan, Geert Harms, Rikst Nynke Schakel, Debora de Jong, Tjasso Blokzijl, Peter Möller, Sibrand Poppema, Bart-Jan Kroesen, Anke van den Berg.   

Abstract

Hodgkin lymphoma (HL) is derived from preapoptotic germinal center B cells, although a general loss of B cell phenotype is noted. Using quantitative reverse transcription-polymerase chain reaction and miRNA microarray, we determined the microRNA (miRNA) profile of HL and compared this with the profile of a panel of B-cell non-Hodgkin lymphomas. The two methods showed a strong correlation for the detection of miRNA expression levels. The HL-specific miRNA included miR-17-92 cluster members, miR-16, miR-21, miR-24, and miR-155. Using a large panel of cell lines, we found differential expression between HL and other B-cell lymphoma-derived cell lines for 27 miRNA. A significant down-regulation in HL compared to non-Hodgkin lymphoma was observed only for miR-150. Next, we performed target gene validation of predicted target genes for miR-155, which is highly expressed in HL and is differentially expressed between HL and Burkitt lymphoma. Using luciferase reporter assays, we validated 11 predicted miR-155 target genes in three different HL cell lines. We demonstrated that AGTR1, FGF7, ZNF537, ZIC3, and IKBKE are true miR-155 target genes in HL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19177201      PMCID: PMC2631141          DOI: 10.1593/neo.08980

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  55 in total

1.  Genesis: cluster analysis of microarray data.

Authors:  Alexander Sturn; John Quackenbush; Zlatko Trajanoski
Journal:  Bioinformatics       Date:  2002-01       Impact factor: 6.937

2.  Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.

Authors:  Andreas Bräuninger; Hans-Heinrich Wacker; Klaus Rajewsky; Ralf Küppers; Martin-Leo Hansmann
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

3.  The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans.

Authors:  B J Reinhart; F J Slack; M Basson; A E Pasquinelli; J C Bettinger; A E Rougvie; H R Horvitz; G Ruvkun
Journal:  Nature       Date:  2000-02-24       Impact factor: 49.962

4.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

5.  Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia.

Authors:  Prabir Ray; Yvan Devaux; Donna B Stolz; Manohar Yarlagadda; Simon C Watkins; Yunbiao Lu; Li Chen; Xiao-Fang Yang; Anuradha Ray
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

6.  The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Authors:  Kerry J Savage; Stefano Monti; Jeffery L Kutok; Giorgio Cattoretti; Donna Neuberg; Laurence De Leval; Paul Kurtin; Paola Dal Cin; Christine Ladd; Friedrich Feuerhake; Ricardo C T Aguiar; Sigui Li; Gilles Salles; Francoise Berger; Wen Jing; Geraldine S Pinkus; Thomas Habermann; Riccardo Dalla-Favera; Nancy Lee Harris; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

7.  Molecular evolution of a microRNA cluster.

Authors:  Andrea Tanzer; Peter F Stadler
Journal:  J Mol Biol       Date:  2004-05-28       Impact factor: 5.469

8.  Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma.

Authors:  Christiane Copie-Bergman; Marie-Laure Boulland; Catherine Dehoulle; Peter Möller; Jean-Pierre Farcet; Martin J S Dyer; Corinne Haioun; Paul-Henri Roméo; Philippe Gaulard; Karen Leroy
Journal:  Blood       Date:  2002-11-21       Impact factor: 22.113

9.  Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.

Authors:  Thomas F E Barth; Josée I Martin-Subero; Stefan Joos; Christiane K Menz; Cornelia Hasel; Gunhild Mechtersheimer; Reza M Parwaresch; Peter Lichter; Reiner Siebert; Peter Möoller
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

10.  Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

Authors:  Ines Schwering; Andreas Bräuninger; Ulf Klein; Berit Jungnickel; Marianne Tinguely; Volker Diehl; Martin-Leo Hansmann; Riccardo Dalla-Favera; Klaus Rajewsky; Ralf Küppers
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

View more
  62 in total

Review 1.  Role of microRNAs in lymphoid biology and disease.

Authors:  Muller Fabbri; Carlo M Croce
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

2.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

3.  Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits.

Authors:  Matteo Brioschi; John Fischer; Roberto Cairoli; Stefano Rossetti; Laura Pezzetti; Michele Nichelatti; Mauro Turrini; Francesca Corlazzoli; Barbara Scarpati; Enrica Morra; Nicoletta Sacchi; Alessandro Beghini
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

4.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

5.  Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors.

Authors:  Jason Harquail; Nicolas LeBlanc; Carine Landry; Nicolas Crapoulet; Gilles A Robichaud
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-07-21       Impact factor: 2.673

6.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

7.  Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables.

Authors:  Semra Paydas; Arbil Acikalin; Melek Ergin; Hikmet Celik; Basak Yavuz; Kahraman Tanriverdi
Journal:  Med Oncol       Date:  2016-03-07       Impact factor: 3.064

8.  Defining Plasma MicroRNAs Associated With Cognitive Impairment In HIV-Infected Patients.

Authors:  Ferdous Kadri; Andrea LaPlante; Mariacristina De Luca; Lisa Doyle; Cruz Velasco-Gonzalez; Jonathan R Patterson; Patricia E Molina; Steve Nelson; Arnold H Zea; Christopher H Parsons; Francesca Peruzzi
Journal:  J Cell Physiol       Date:  2016-04       Impact factor: 6.384

9.  A high throughput experimental approach to identify miRNA targets in human cells.

Authors:  Lu Ping Tan; Erwin Seinen; Gerben Duns; Debora de Jong; Ody C M Sibon; Sibrand Poppema; Bart-Jan Kroesen; Klaas Kok; Anke van den Berg
Journal:  Nucleic Acids Res       Date:  2009-09-04       Impact factor: 16.971

10.  MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.

Authors:  Prasun J Mishra; Bo Song; Pravin J Mishra; Yuan Wang; Rita Humeniuk; Debabrata Banerjee; Glenn Merlino; Jingfang Ju; Joseph R Bertino
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.